本文へスキップ

医薬品リファレンス

Daridorexant

Daridorexant is a medicine in the class central nervous system. It is used for insomnia.

最終更新日 出典: US FDA label

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

要点

薬効分類
Central Nervous System
ATCコード
N05CJ03
一般的な剤形
錠剤
既知の相互作用
173 (重大: 12 · 中等度: 146 · 軽度: 15)
商品名
2
国・市場
2

剤形、規格、商品名は国によって異なります。お手元の製品をご確認ください。

何に使われるか

作用のしくみ

Presumed to act through antagonism of orexin receptors; blocking binding of orexin A and orexin B to OX1R and OX2R is thought to suppress wake drive.

成人の通常用量(添付文書の要約)

Insomnia (sleep onset and/or maintenance): 25 mg to 50 mg orally once per night, within 30 minutes of going to bed, with at least 7 hours remaining before planned awakening.

添付文書の最初の用法・用量の行のみの要約です。用法・用量の全項目はアプリでご覧いただけます。

妊娠と授乳

妊娠
Unknown No human pregnancy data. In rats and rabbits, doses up to 8-10 times human exposure caused no fetal toxicity or malformations. A US pregnancy registry exists. Prefer non-drug measures for insomnia in pregnancy; use only if clearly needed.
授乳
Safe Passes into milk in very low amounts (well under 1% of the mother's weight-adjusted dose). LactMed: not a reason to stop breastfeeding. US label: watch the infant for excessive sedation; also check feeding and weight gain.

報告されている副作用

  • Headache
  • Somnolence or fatigue
  • Dizziness
  • Nausea
  • Nightmares or abnormal dreams (post-marketing)
  • Hypersensitivity including angioedema, rash, urticaria (post-marketing)

禁忌

  • Narcolepsy.
  • History of hypersensitivity to daridorexant or any component of the product; angioedema with pharyngeal involvement has been reported.

注意が必要な方

  • CNS depressant effects and daytime impairment, which may persist for several days; caution against next-day driving; risk increases with less than a full night of sleep remaining, higher doses, or other CNS depressants; falls risk especially in the elderly.
  • Worsening of depression and suicidal ideation; use with caution in patients with depressive symptoms and monitor suicide risk.
  • Sleep paralysis, hypnagogic/hypnopompic hallucinations and cataplexy-like symptoms may occur.

妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。

主な相互作用 (173)

All 173 interactions, with severity and what to do

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、Daridorexantの完全なモノグラフ(用量、妊娠・授乳、副作用、警告、すべての相互作用)を表示できます。

  • Dosing by age, kidney and liver function, and further dose lines
  • Renal and hepatic dose adjustments
  • Dosing in older adults
  • How to give it
  • Pharmacokinetics
  • Patient counselling points
  • Food interactions

WebでPro+を7日間無料でお試し。カード登録不要。

よくある質問

What is Daridorexant used for?

Daridorexant is a medicine in the class central nervous system. It is used for Insomnia.

What side effects have been reported with Daridorexant?

Headache, Somnolence or fatigue, Dizziness, Nausea, Nightmares or abnormal dreams (post-marketing), Hypersensitivity including angioedema, rash, urticaria (post-marketing).

Can Daridorexant be taken in pregnancy or while breastfeeding?

Pregnancy: Unknown. No human pregnancy data. In rats and rabbits, doses up to 8-10 times human exposure caused no fetal toxicity or malformations. A US pregnancy registry exists. Prefer non-drug measures for insomnia in pregnancy; use only if clearly needed. Breastfeeding: Safe. Passes into milk in very low amounts (well under 1% of the mother's weight-adjusted dose). LactMed: not a reason to stop breastfeeding. US label: watch the infant for excessive sedation; also check feeding and weight gain.

What does Daridorexant interact with?

MediHelp lists 173 known interactions for Daridorexant. Major: 12 · Moderate: 146 · Minor: 15. The most serious include Amobarbital, Apalutamide, Clarithromycin.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 医薬品リファレンス

アプリを入手 ログイン